AndreasRimnerMD

Radiation Oncology • New York, NY

Thoracic Cancer

Associate Attending

Join to view full profile

Dr. Rimner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rimner's full profile

Already have an account?

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2006 - 2010
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2005 - 2006
Eberhard Karls University Faculty of MedicineClass of 2003

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 2010 - 2026
NJ State Medical License 2022 - 2025
American Board of Radiology Radiation Oncology

Clinical Trials

Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer Start of enrollment: 2008 Jul 01
Completed
Phase 1, Phase 2
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer Start of enrollment: 2013 Jul 05
Active, not recruiting
Phase 1
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients Start of enrollment: 2013 Dec 16
Active, not recruiting
Not Applicable
Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer Start of enrollment: 2014 Apr 01
Active, not recruiting
Not Applicable
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma Start of enrollment: 2017 Dec 20
Completed
Phase 1, Phase 2
A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer Start of enrollment: 2018 Jul 12
Active, not recruiting
Phase 1
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma Start of enrollment: 2020 Jan 29
Terminated
Phase 3
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy Start of enrollment: 2021 Jan 27
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

109 citations
Pleural Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma
Kenneth E. Rosenzweig, Marjorie G. Zauderer, B. Laser, Lee M. Krug, Ellen Yorke
International Journal of Radiation Oncology, Biology, Physics. 2012-07-15
253 citations
Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistanc...
Helena A. Yu, Camelia S. Sima, James Huang, Stephen B. Solomon, Andreas Rimner
Journal of Thoracic Oncology. 2013-03-01
23 citations
Segmenting lung tumors on longitudinal imaging studies via a patient-specific adaptive convolutional neural network.
Chuang Wang, Neelam Tyagi, Andreas Rimner, Yu-Chi Hu, Harini Veeraraghavan
Radiotherapy and Oncology. 2019-02-01

Journal Articles

Design and Validation of a MV/kV Imaging Based Markerless Tracking System for Assessing Real Time Lung Tumor Motion
Andreas Rimner, MD, Medical Physics
Stereotactic Body Radiation Therapy (SBRT) Improves Local Control and Overall Survival Compared to Conventionally Fractionated Radiation for Stage I Non-Small Cell Lun...
Kenneth E Rosenzweig, Fauzia Shaikh, Daphna Y Gelblum, Shaun U Din, Andreas Rimner, Abraham J Wu, Acta Oncologica

Authored Content

The Expanding Role of Radiation Therapy for Thymic MalignanciesNovember 2017

Press Mentions

Local Therapy Extends Use of Targeted Drugs in Oligoprogressive Lung CancerOctober 20th, 2022
Treatment Planning and Outcomes Effects of Reducing the Preferred Mean Esophagus Dose for Conventionally Fractionated Non‐Small Cell Lung Cancer RadiotherapyJanuary 25th, 2021
The Expanding Role of Radiation Therapy for Thymic MalignanciesSeptember 3rd, 2020
Join now to see all

AndreasRimnerMD

Dr. Rimner is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Authored Content

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.